Table 1.
Clinical and Procedural Characteristics of the Overall Population: TAVI Versus CA/PCI
| Baseline Characteristics | Total Population (N=977) | TAVI (n=489; 50.1%) | CA/PCI (n=488; 49.9%) | P Value |
|---|---|---|---|---|
| Sex (% male) | 57.60% | 47.60% | 58.60% | <0.001 |
| Hypertension | 82.10% | 51.50% | 48.50% | 0.351 |
| Diabetes mellitus | 31.40% | 30.30% | 32.50% | 0.484 |
| Dyslipidemia | 59.20% | 59.60% | 58.70% | 0.785 |
| Anemia | 34.30% | 50.10% | 18.40% | <0.001 |
| eGFR<60 mL/min | 56.20% | 73.70% | 39.80% | <0.001 |
| Age, y | 75.63±11.53 | 81.41±7.31 | 69.93±12.09 | <0.001 |
| BMI | 26.43±4.60 | 25.80±4.51 | 27.05±4.62 | 0.927 |
| Basal creatinine, mg/dL | 1.15±0.49 | 1.21±0.54 | 1.09±0.42 | <0.001 |
| Basal eGFR, mL/min | 63.14±32.11 | 50.21±23.34 | 75.25±34.41 | <0.001 |
| LVEF, % | 52.63±12.34 | 53.50±13.12 | 51.44±11.10 | 0.54 |
| Contrast medium, mL | 143.91±81.76 | 140.63±68.44 | 146.12±89.60 | 0.353 |
BMI indicates body mass index; CA, coronary angiography; CA/PCI, coronary angiography/percutaneous coronary intervention; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; and TAVI, transcatheter aortic valve implantation.